Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-21

FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA granted a supplemental approval for escitalopram oral solution from Chartwell RX, LLC under ANDA090477, adding an oral solution dosage form for this generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram oral solution (escitalopram oral solution)

Snippet

SUPPL AP for ESCITALOPRAM ORAL SOLUTION (ESCITALOPRAM ORAL)